Global Transdermal Patch for Pain Relief Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare
Publisher : MRA | Format : PDF
Global Transdermal Patch for Pain Relief Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application
Pain Relief patch is a kind of adhesive patch that sticks to the skin and can deliver a specific dose of medicine to the body through the skin. Usually, this promotes the healing of injured parts of the body.
Transdermal Patch for Pain Relief report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Patch for Pain Relief market is projected to reach US$ 6315 million in 2029, increasing from US$ 4830.4 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from OTC and Rx are the major drivers for the industry.
The transdermal patch market is driven by the growing demand for convenient and non-invasive drug delivery methods. These patches offer advantages such as controlled and sustained drug release, improved patient compliance, and reduced side effects compared to traditional oral medications. The rising prevalence of chronic diseases requiring long-term medication regimens further accelerates market growth. Additionally, the ease of use and potential for self-administration align with patient preferences for at-home treatments. However, the market faces challenges, including the complexity of formulating drugs suitable for transdermal delivery and ensuring consistent and accurate dosing. Regulatory hurdles related to drug stability, patch adhesion, and manufacturing standards also pose challenges. Successful navigation of these challenges is crucial for stakeholders in the transdermal patch market to harness its growth potential and provide effective, user-friendly solutions for drug delivery needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Patch for Pain Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
Hisamitsu
Viatris
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Segment by Type
Lidocaine Patch
Diclofenac Patch
Indomethacin Patch
Fentanyl Patch
Peppermint Patch
Methyl Salicylate Patch
Capsaicin Patch
Other
OTC
Rx
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Patch for Pain Relief market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Patch for Pain Relief, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Patch for Pain Relief industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Patch for Pain Relief in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Patch for Pain Relief introduction, etc. Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Patch for Pain Relief market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Transdermal Patch for Pain Relief report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Transdermal Patch for Pain Relief market is projected to reach US$ 6315 million in 2029, increasing from US$ 4830.4 million in 2022, with the CAGR of 3.8% during the period of 2024 to 2029. Demand from OTC and Rx are the major drivers for the industry.
The transdermal patch market is driven by the growing demand for convenient and non-invasive drug delivery methods. These patches offer advantages such as controlled and sustained drug release, improved patient compliance, and reduced side effects compared to traditional oral medications. The rising prevalence of chronic diseases requiring long-term medication regimens further accelerates market growth. Additionally, the ease of use and potential for self-administration align with patient preferences for at-home treatments. However, the market faces challenges, including the complexity of formulating drugs suitable for transdermal delivery and ensuring consistent and accurate dosing. Regulatory hurdles related to drug stability, patch adhesion, and manufacturing standards also pose challenges. Successful navigation of these challenges is crucial for stakeholders in the transdermal patch market to harness its growth potential and provide effective, user-friendly solutions for drug delivery needs.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Transdermal Patch for Pain Relief market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Hisamitsu
Viatris
Johnson & Johnson
Teva
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
GSK
Haw Par
Nichiban
Laboratoires Genevrier
BLUE-EMU
IBSA Group
Pfizer
Performance Health
Segment by Type
Lidocaine Patch
Diclofenac Patch
Indomethacin Patch
Fentanyl Patch
Peppermint Patch
Methyl Salicylate Patch
Capsaicin Patch
Other
Segment by Application
OTC
Rx
Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Transdermal Patch for Pain Relief market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Transdermal Patch for Pain Relief, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Transdermal Patch for Pain Relief industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Transdermal Patch for Pain Relief in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Transdermal Patch for Pain Relief introduction, etc. Transdermal Patch for Pain Relief Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Transdermal Patch for Pain Relief market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices